Best Suki Alternatives in 2026: 6 AI Scribes for EHR-Integrated Practices

Glass Health: a strong fit for practices that want ambient notes plus clinical decision support across Epic, eClinicalWorks, athenahealth, and Elation workflows.
Abridge: an enterprise option for large health systems evaluating ambient documentation.
DeepScribe: an option for clinics evaluating a workflow-focused ambient documentation platform.
Microsoft Dragon Copilot: an option for organizations already aligned with Microsoft’s clinical workflow ecosystem.
Freed: an option for individual clinicians and small practices that want visible website pricing and a try-before-you-buy path.
Nabla: an option for teams evaluating ambient AI, dictation, and real-time intelligence in one workflow.

Tool	Best for	Pricing signal	EHR workflow note	Key differentiator
Glass Health	Practices that want ambient notes + CDS in one workflow	Lite free; Starter $20/mo; Pro $90/mo; Max $200/mo	Epic, eClinicalWorks, athenahealth workflows	Ambient scribe + clinical decision support + SMART on FHIR-based chart-context workflow
Abridge	Large health systems	Contact Abridge directly	Verify current workflow details during vendor review	Enterprise-grade AI for clinical conversations
DeepScribe	Clinics evaluating workflow-focused ambient documentation	Contact DeepScribe directly	Verify current workflow details during evaluation	Ambient OS for complex workflows
Microsoft Dragon Copilot	Microsoft-aligned organizations	Contact Microsoft directly	Verify current workflow details during evaluation	Your AI clinical assistant
Freed	Individual clinicians and small practices	Starter $39/mo + “Try for free”	Verify current workflow details directly with Freed	Made for small practices
Nabla	Teams evaluating broader clinician-workflow support	“Try it for free” + talk to team	Verify current workflow details directly with Nabla	Ambient AI, dictation, and real-time intelligence

Vendor websites vary in how much current detail they publish. This page keeps competitor claims to pricing signals and homepage positioning visible on vendor-owned pages, then goes deeper on what Glass does in practice.

The best Suki alternatives in 2026 solve different buying problems. Some are built for centralized enterprise review, some make it easier for smaller groups to start with visible pricing, and some matter most when chart context and clinical support belong in the same workflow as note generation. This page is written for practices in displacement mode: you already know ambient AI matters, and now you need the right fit on pricing, rollout style, and EHR access. Competitor sections stay close to vendor-owned sources, and the Glass section goes deeper on the documented workflow so you can understand what a real switch would look like. If you want a direct head-to-head, start with Glass vs Suki. If you want a broader category view first, see Best AI Medical Scribe. For related buying content, see the Glass Health resources hub.

1. Glass Health

What it is: Glass Health combines ambient documentation with clinical decision support. Ambient CDS serves as an intelligent clinical assistant during the patient encounter and includes real-time clinical insights.

Best for: EHR-integrated practices leaving Suki that want note generation and clinical support in the same workflow, especially teams that want to start with a low-commitment pilot and then decide whether to add EHR context.

Pricing: Glass Health lists pricing openly: Lite free, Starter $20/month, Pro $90/month, and Max $200/month.

EHR integrations: We list Epic, eClinicalWorks, athenahealth, and Elation. Confirm current setup details directly with Glass.

Strengths: Glass is a practical option when the buying team wants a clear rollout path from day one. A practice can begin with a published pricing ladder, test note quality with a small cohort, and then decide whether EHR context belongs in the next phase. That sequence matters because it lets the team answer one question at a time: first whether clinicians like the core ambient workflow, then whether clinical support is valuable, and finally whether chart context improves the experience enough to justify implementation work.

Glass also gives buyers one workflow to evaluate instead of two separate projects. The same product can support draft documentation and clinical decision support, which is a different evaluation from testing a note generator in isolation. On the Glass side, the buying conversation becomes more concrete: does the note save editing time, do the real-time clinical insights help during the encounter, and does chart context improve the result? That is usually a better framing than treating ambient AI as a transcript-only tool.

Another reason Glass stands out in a Suki replacement process is that the product story is easy to map to an adoption plan. Teams can start with a clinician-level trial, move to a structured pilot, and only then decide whether to add EHR-linked context. That makes it easier to separate workflow value from integration value. If the note quality is strong but the organization is not ready for EHR work, Glass can still be evaluated on the core ambient experience first.

How Glass’s EHR workflow works

Glass leverages SMART on FHIR technology for supported EHR-connected workflows and can use authorized chart context for documentation and clinical decision support. For Epic, eClinicalWorks, athenahealth, and Elation deployments, confirm the current workflow and setup details directly with Glass.

Operationally, that defines Glass as a chart-context workflow. The product can use patient context to support documentation and clinical decision support, while clinicians review and finalize output through the approved process. If your migration plan assumes a specific in-chart workflow, scope that separately. If your goal is chart-aware ambient documentation in a controlled permission model, Glass is straightforward to evaluate on that basis.

That workflow model also makes security and implementation conversations more concrete. Buyers know what to ask: which data needs to be available, how access governance should work, and how clinician review fits the workflow before they commit to a larger rollout.

How to plan enablement by EHR

For Epic organizations, benchmark the workflow in Hyperdrive and decide which chart elements matter most to clinicians during a pilot. The most useful implementation plans start with a narrow question set: what context should Glass pull, how often will clinicians rely on it, and which encounter types make the benefit easiest to see? That keeps the evaluation grounded in clinician workflow instead of abstract integration language.

For athenahealth, eClinicalWorks, and Elation, plan the connection as a direct SMART on FHIR-based workflow setup. The right mental model is direct enablement with Glass and your EHR team. That does not make the workflow less useful; it just means implementation planning should start with patient-context needs, approvals, and access setup.

A practical way to evaluate Glass is to separate the decision into three layers. First, judge the ambient note output on its own. Second, decide whether the clinical decision support layer adds value in real encounters. Third, determine whether EHR context improves enough of the workflow to justify the added implementation work. Breaking the evaluation into those layers usually produces a better decision than treating the entire rollout as one all-or-nothing project.

How to pilot Glass before a wider rollout

The simplest pilot starts with a small group of clinicians and a short list of questions. Is the draft note close enough to save time? Does the CDS component surface helpful support without slowing the visit? Is the chart context sufficient for the encounter types that matter most? And does the current pricing tier match the size of the rollout you actually want? Glass is easier to evaluate when you answer those questions in order.

That is also where published pricing helps. A team can start with Lite, see whether clinicians actually adopt the workflow, and then decide whether Starter, Pro, or Max fits the next phase. Even if the eventual goal is an EHR-linked deployment, starting with a narrow pilot keeps the project grounded in real usage rather than assumptions.

It also helps to define success metrics before the pilot starts. Practices usually learn the most when they track note-editing time, clinician satisfaction, consistency of draft quality, and whether chart context changes how often the note feels encounter-specific. Those are practical measures that leadership can review without turning the project into a feature-count exercise.

Weaknesses: Glass should be evaluated as part of the clinician workflow rather than as a generic replacement for every in-chart action. EHR-linked rollout also requires an IT conversation because patient-context needs, access governance, and clinician review need to be set up intentionally.

Switch from Suki if... you want transparent pricing and ambient documentation plus clinical decision support in one workflow. Glass is especially practical when your team wants to pilot first, validate clinician adoption, and add chart context only after the core workflow proves itself.

2. Abridge

What it is: Abridge describes itself as “Enterprise-grade AI for clinical conversations—trusted by the largest healthcare systems”.

Best for: Large health systems that want an enterprise ambient documentation evaluation.

Pricing: Contact Abridge directly for current pricing and evaluation details.

EHR integrations: Verify current integration and deployment details directly with Abridge during diligence.

Strengths: Abridge belongs on the shortlist when the buyer is a health system rather than one clinician. Its public positioning is explicitly enterprise-oriented, which makes it a reasonable benchmark when the evaluation includes formal governance, centralized review, and physician-leadership review. If your move off Suki is being managed by IT, informatics, compliance, and contracting together, Abridge is a relevant enterprise option to review.

Weaknesses: Gather current pricing, integration, and technical detail directly from Abridge early in the process so your team is comparing live vendor inputs instead of assumptions.

Switch from Suki if... your organization buys through a formal enterprise motion and wants to evaluate another ambient documentation vendor positioned for health-system rollout.

3. DeepScribe

What it is: DeepScribe says, “Meet the ambient OS that takes care of your most complex workflows.”

Best for: Clinics evaluating an ambient documentation platform with workflow-focused positioning.

Pricing: Contact DeepScribe directly for current pricing details.

EHR integrations: Verify current integration and deployment details directly with DeepScribe.

Strengths: DeepScribe is worth reviewing if your switch away from Suki is driven by workflow questions as much as note creation. Its homepage language centers on an ambient OS and complex workflows, which gives buyers a clear lens for evaluation. If your practice wants to compare how different vendors frame the work around documentation, not only the final note output, DeepScribe is a sensible name to include.

Weaknesses: The practical next step is demo-led diligence. Validate current deployment, connector, and technical details directly with DeepScribe before you make workflow assumptions.

Switch from Suki if... you want to test a workflow-oriented ambient documentation platform and you are comfortable starting the evaluation through a guided product conversation.

4. Microsoft Dragon Copilot

What it is: Microsoft’s Dragon Copilot page describes the product as “Your AI clinical assistant.”

Best for: Organizations already aligned with Microsoft’s clinical workflow ecosystem.

Pricing: Contact Microsoft directly for current Dragon Copilot pricing and evaluation details.

EHR integrations: Verify current integration and deployment details directly with Microsoft.

Strengths: Microsoft Dragon Copilot is a natural option for organizations that already evaluate clinical workflow software through Microsoft. If your Suki replacement process sits inside a broader enterprise software review, Dragon Copilot belongs in that discussion. The public framing is broad enough that buyers can assess it as part of a larger workflow, governance, and support conversation.

Weaknesses: Treat this as an enterprise-led evaluation. Current pricing, implementation specifics, and exact workflow scope should be gathered directly from Microsoft as part of the buying process.

Switch from Suki if... your organization prefers to evaluate ambient documentation in the broader context of Microsoft’s clinical workflow ecosystem.

5. Freed

What it is: Freed’s site says it is “Made for small practices” and shows public plan pricing plus a “Try for free” path.

Best for: Individual clinicians and small practices.

Pricing: Freed publicly shows Starter at $39/month, along with paid plans, and includes a “Try for free” path. Verify current trial terms directly with Freed.

EHR integrations: Verify current integration and deployment details directly with Freed.

Strengths: Freed is attractive when the evaluation begins with one clinician or a very small group. Public website pricing makes the budget math visible immediately, and the “Try for free” path makes it easy to test the product before a broader purchase decision. If your Suki replacement project is really a clinician-level adoption project, that kind of visible entry point can matter a lot.

Weaknesses: If EHR workflow is central to your decision, confirm the current integration path directly with Freed before assuming it matches the needs of your practice. The right fit for a small practice depends not only on note quality, but also on how much chart context and workflow structure you need.

Switch from Suki if... you want a fast, small-practice-friendly evaluation path with visible website pricing and a simple way to get clinicians into a live trial.

6. Nabla

What it is: Nabla’s homepage highlights “Ambient AI, dictation, and real-time intelligence.”

Best for: Teams evaluating a broader clinician-workflow conversation alongside ambient documentation.

Pricing: Nabla’s homepage includes a “Try it for free” CTA and a “Talk to our team” path. Verify current plan details directly with Nabla.

EHR integrations: Verify current integration and deployment details directly with Nabla.

Strengths: Nabla is worth including when your evaluation is broader than note capture alone. Its public framing combines ambient AI, dictation, and real-time intelligence, which points buyers toward a wider workflow discussion. For medical groups and health systems that want to think about documentation quality and clinician assistance together, that positioning can make Nabla a relevant comparison point.

Weaknesses: Confirm current plan structure, deployment model, and exact integration path directly with Nabla during diligence so the product is judged on current materials rather than category assumptions.

Switch from Suki if... you want to compare a broader workflow-oriented ambient AI product and you are already prepared for a team-level or organization-level evaluation process.

Why switch from Suki to Glass Health

Most practices moving off Suki are trying to solve a practical migration problem, not win a feature-count debate. They want an ambient workflow that clinicians will actually use, a clear sense of pricing before the project gets too large, and an honest answer on how much EHR context belongs in phase one. Glass is a strong option because the Glass Health workflow and technical access model are both easy to understand.

1) Start with a published pricing ladder

Glass Health lists Lite free, Starter $20/month, Pro $90/month, and Max $200/month. That matters because the first conversation can be concrete. A practice can decide whether it wants an individual trial, a departmental pilot, or a broader rollout before the rollout gets heavy. Even if the eventual deployment is larger, published pricing helps the team talk about actual budget ranges instead of abstract packaging.

It also makes pilot design easier. A small group can start on a low-commitment tier, gather feedback, and only expand if clinicians are actually using the workflow. That sequence is especially helpful when the organization is still deciding how much integration work belongs in the first phase.

2) Put ambient notes and CDS in one workflow

Glass combines ambient scribing and clinical decision support. The ambient workflow serves as an intelligent clinical assistant during the encounter and highlights real-time clinical insights. For many buyers, that is the key reason to take the product seriously. The evaluation is not only about whether the note reads well. It is also about whether the workflow gives clinicians useful support while they document.

If your team is trying to reduce context switching and avoid assembling separate tools for note generation and clinical support, Glass gives you a single workflow to pilot. That changes the evaluation from a narrow transcription question into a broader clinician-productivity question.

3) Use chart context with clinician review

We list Epic, eClinicalWorks, athenahealth, and Elation. The practical implication is simple: Glass can bring chart context into the workflow, while clinicians review and finalize output through the approved process. That can be a good fit for organizations that want the benefits of chart-aware ambient documentation without making every in-chart action part of phase one.

Glass leverages SMART on FHIR technology for supported EHR-connected workflows. For Epic teams, the right question is how the workflow performs in Hyperdrive with the authorized chart context clinicians care about most. For athenahealth, eClinicalWorks, and Elation, plan direct chart-context workflow enablement with Glass and your EHR team.

4) Roll out in phases

A practical Glass rollout starts small. First, judge note quality. Second, decide whether CDS is helpful enough to change daily behavior. Third, determine whether EHR context improves enough encounters to justify the technical work. That phased sequence is usually cleaner than trying to solve clinician adoption, governance, integration, and budgeting all at once.

It also gives leadership a better way to compare outcomes. Instead of asking whether the whole project worked instantly, the team can ask which layer of the workflow created value and what should expand next. That produces a more disciplined switch plan and gives clinicians a fairer way to evaluate the product in real encounters.

Switch from Suki to Glass Health

FAQ

Is Suki HIPAA compliant?

Suki’s site says it is HIPAA compliant. That is a useful starting point, but it should not be the end of the review. Before you switch, confirm data-handling terms, retention settings, security materials, and implementation scope directly with Suki. That is the right standard for any vendor in this category.

Which Suki alternatives show a free starting point on their websites?

If you want visible website signals for a lower-commitment start, Glass Health, Freed, and Nabla are the clearest examples on this page. Glass Health lists Lite at $0. Freed’s site includes a “Try for free” path alongside paid plans. Nabla’s homepage includes a “Try it for free” CTA. The details are not identical, so verify current terms directly with each vendor before you use those entry points as part of planning.

Does Glass Health integrate with Epic, eClinicalWorks, athenahealth, and Elation?

Yes. We list Epic, eClinicalWorks, athenahealth, and Elation. Glass should be evaluated as a chart-context workflow with clinician review rather than a generic final-charting claim. If your team wants a clean first deployment, that distinction matters because it keeps the implementation focused on patient context and workflow fit.

How should I compare Glass Health and Suki on price?

Start with Glass Health’s current pricing: Lite free, Starter $20/month, Pro $90/month, and Max $200/month. That gives you a concrete baseline for planning a clinician trial, a small-group pilot, or a broader rollout discussion. Then request Suki’s current pricing and packaging directly from Suki, since vendor terms can change over time. The useful comparison is not only sticker price, but also what level of rollout you want to support in the first phase.

Can I trial Glass Health before switching from Suki?

Yes. The simplest way is to start with Glass Lite, which is free. That lets clinicians test note quality, workflow comfort, and the overall feel of the product before anyone commits to a larger change. If the core ambient workflow works for your practice, you can then decide whether a paid tier and an EHR-linked setup make sense. That phased approach usually produces better feedback than trying to answer every integration question on day one.

What Glass Health capabilities should I compare against Suki?

The cleanest checklist is what Glass clearly offers today: ambient scribing plus clinical decision support, a published pricing ladder, and workflows for Epic, eClinicalWorks, athenahealth, and Elation. If your practice is comparing Glass and Suki, use those capabilities as the starting framework. Then ask your clinicians whether the note output is useful, whether the CDS layer helps, and whether chart context is the right level of integration for the rollout you want.

How should emergency medicine teams evaluate a Suki alternative?

Emergency medicine teams should focus on speed, note structure, clinician editing burden, and whether chart context shows up at the right moment in a fast workflow. That is more useful than relying on broad category language. Glass combines ambient scribing with clinical decision support in one workflow, so an ED team can test whether that pairing actually helps in high-tempo documentation. The right way to decide is a pilot with real encounter types, not a feature checklist alone.

Product

Company

Legal